US Drug Recall Register
Class II · Moderate risk Ongoing Initiated Nov 7, 2023 (3 years ago)

Naproxen Tablets, USP 250mg, 100-count bottle, Rx Only, Manufactured by: Glenmark…

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Labeling: Label Mix-Up-Indomethacin bottles may be labeled as Naproxen

What was recalled

Naproxen Tablets, USP 250mg, 100-count bottle, Rx Only, Manufactured by: Glenmark Pharmaceuticals Ltd. Colvale-Bardez, Goa 403513, India, Manufactured for: Glenmark Pharmaceuticals Inc., USA Mahwah, NJ 07430, NDC 68462-188-01.

Recalling firm
Glenmark Pharmaceuticals Inc., USA
NDC code
68462-188-01
Origin
NJ, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0124-2024

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Naproxen recalls

See all